CalciMedica (CALC) Assets Average (2020 - 2026)
CalciMedica's (CALC) quarterly Assets Average came in at $11.1 million in Q1 2026, down 50.82% YoY from $22.6 million in Q1 2025, and down 22.12% on a QoQ basis from $14.3 million in Q4 2025.
CalciMedica (CALC) Assets Average (2020 - 2026) Analysis & Trends
CalciMedica (CALC) has 7 years of Assets Average data on file, last reported at $11.1 million in Q1 2026.
- Quarterly Assets Average fell 50.82% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (down 50.82% YoY) and the FY2025 annual result came in at $16.7 million, up 4.4% from the prior year.
- Assets Average slipped to $11.1 million in Q1 2026, from $14.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $64.8 million in Q1 2022 to a low of $11.1 million in Q1 2026.
- A 5-year average of $26.0 million and a median of $19.7 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average plunged 70.68% — and 2024, when it increased 28.46%.
- Tracing CALC's Assets Average over 5 years: stood at $24.4 million in 2022, then slumped by 42.46% to $14.0 million in 2023, then advanced by 28.46% to $18.0 million in 2024, then slipped by 20.84% to $14.3 million in 2025, then decreased by 22.12% to $11.1 million in 2026.
- The last three Assets Average figures came in at $11.1 million (Q1 2026), $14.3 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | 14.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.06 Mn |
| Mar 31, 2026 | 11.10 Mn |
| Dec 31, 2025 | 14.25 Mn |
| Sep 30, 2025 | 17.00 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 22.57 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Jun 30, 2024 | 24.09 Mn |
| Mar 31, 2024 | 19.66 Mn |
| Dec 31, 2023 | 14.02 Mn |
| Sep 30, 2023 | 18.05 Mn |
| Jun 30, 2023 | 27.46 Mn |
| Mar 31, 2023 | 19.01 Mn |
| Dec 31, 2022 | 24.36 Mn |
| Sep 30, 2022 | 49.69 Mn |
| Jun 30, 2022 | 57.30 Mn |
| Mar 31, 2022 | 64.84 Mn |
| Dec 31, 2021 | 72.86 Mn |
| Sep 30, 2021 | 79.73 Mn |